Table 4.

Expression level of proteins in NF-κB and NLRP3 signaling pathways upon LGG-EVs treatments.

Proteins/Groups	Control	DSS	DSS + LGG-EVs
p-p65/p65	0.81 ± 0.03 ***	1.11 ± 0.06	0.55 ± 0.02 ***
ASC	0.07 ± 0.00 **	0.08 ± 0.01	0.07 ± 0.01 *
NLRP3	0.46 ± 0.03 *	0.54 ± 0.03	0.48 ± 0.04 (p = 0.058)

Normalized to β-actin. Data were presented as mean ± SD (n = 3). * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. DSS group. D’Agostino and Pearson test were used to verify normality of distribution of data.